From 1971 to 1985 a total of 122 patients with non-distant metastatic
nasopharyngeal carcinoma were treated at the Norwegian Radium Hospital
with radiation doses that increased from 50 Gy (at 2 Gy/fractions) to
70 Gy (at 2 Gy/fractions) during the treatment period. Possible relat
ionship between the increase in dose and survival time was investigate
d. The median cancer-specific survival time was 50 months, and the med
ian crude survival time 38 months. No correlation was found between ra
diation dose and survival time. In a multivariate analysis histology w
as found to be the most important prognostic factor for survival with
a relative risk of death from cancer of 3.4 and 3.2 for non-keratinizi
ng carcinoma and squamous cell carcinoma respectively compared with un
differentiated carcinoma. When assessed in terms of N category the rel
ative death risk for N2/N3 was 2.1 compared to NO/Nl.